Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-01 @ 3:20 PM
Study NCT ID:
NCT00220168
Status:
COMPLETED
Last Update Posted:
2009-12-16
First Post:
2005-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jane Lawrence
Old Organization:
Royal Marsden NHS Foundation Trust